semaglutide and dopamine GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights Therapeutic Perspectives GLP-1 receptor agonist semaglutide reduces

For patients on bupropion, this conservative approach has merit because it reduces the likelihood of severe GI side effects that could lead to the dehydration and electrolyte imbalances that increase seizure risk

Sum CF, Winocour PH, Agius L, and et al

12-month doctor-guided follow-up Complimentary visits keep healing on track

Both Semaglutide and Tirzepatide are medications that have shown significant effectiveness in promoting consistent and sustainable weight loss through appetite suppression, regulation of blood sugar, enhanced calorie expenditure, body fat reduction, and satiety for greater portion control

However, more research is needed to confirm these findings and to understand the safety and long-term effects of using these medicines for cancer prevention